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A B S T R A C T Medullasin, a new serine protease found in bone marrow cells, increased markedly human natural killer cell activity. Whereas the natural killer cell activity measured immediately after the treatment with medullasin remained almost on the same level as the control, an incubation at 37°C for several hours increased markedly the natural killer cell activity of the lymphocytes treated with medullasin. Enhancement of the natural cytotoxicity was caused by the treatment with physiologic concentrations of the protease (5-20 ,ug/ml). Inhibitors of medullasin such as phenylmethylsulfonyl fluoride and elastatinal prevented the activation of natural cytotoxicity. Depletion of lymphocytes bearing Fc receptors for IgG abolished the enhancement of natural killer cell activity by medullasin. Interferon activity was not detected in the supernatant of lymphocyte cultures stimulated with medullasin. The medullasin enhanced further the natural killer cell activity of lymphocytes stimulated with interferon. Medullasin activity was detected neither in unstimulated nor stimulated (by concanavalin A or phytohemagglutinin) human lymphocytes. The protease was released easily from human mature granulocytes into culture medium. It is considered from these results that the level of human natural killer cell activity is regulated by medullasin released by mature granulocytes. INTRODUCTION A new serine protease was found in bone marrow cells including both erythroblasts and granulocytes (1) . It was crystallized from human bone marrow cells, and therefore named medullasin (from Latin medulla ossium, bone marrow). The molecular weight of the protease is 31,800, and optimum pH 8.5. Histidine, serine, and one carboxyl group were shown to be essential to the protease activity. It resembles elastase, without being identical with it. Equimolar amounts of a1-antitrypsin inhibit the protease. From subcellular fracReceived for publication 2 August 1981 and in revised form 28 January 1982. tionation studies using rat erythroblasts as the material, medullasin is considered to be located on the inner mitochondrial membrane. Medullasin in erythroblasts was shown to participate in the development of a certain kind of anemia (2, 3) . In the course of investigating the biologic significance of medullasin in granulocytes we found that levels of medullasin in granulocytes were elevated in certain pathological conditions such as chronic inflammations and cancer (submitted for publication). Furthermore, medullasin was found to enhance markedly human natural killer cell activity.
Natural killer cells, which show cytotoxicity against target cells without prior sensitization, are considered as one of the primary defense mechanism of animals against cancer and viral infections (4) (5) (6) (7) . In human peripheral blood they are considered to be the lymphocytes which bear the receptor for Fc portion of IgG but lack immunoglobulins on the cell surface (8) (9) (10) . It is postulated that natural killer cells play equal or more important roles than T and B lymphocytes in the natural conditions of defense mechanisms against carcinogenesis and viral or bacterial infections (11, 12) . The natural killer cell activity is reported to be modified by a variety of factors. Interferon (13, 14) and interferon inducers, such as viral infections, tumor cells, Bacille Calmette-Guerin(BCG), Corynebacterium parvum, and certain chemicals (15) (16) (17) (18) (19) (20) enhance natural killer cell activity. Also tuftsin and interleukin-2 were reported to stimulate natural cytotoxicity of mice (21, 22) . On the other hand, cyclophosphamide, hydrocortisone, and cholera toxin inhibit natural killer cell activity (23, 24) . Also protease inhibitors and protease substrates were reported to inhibit cytotoxic T lymphocyte activity (25) , antibody-dependent cellmediated cytotoxicity (26) , and natural killer cell activity (27) . Furthermore, macromolecular protease inhibitors, such as a1-antitrypsin and a1-antichymotrypsin, inhibit human natural cytotoxicity (28) . It is considered from these results that proteases may be involved in lymphocyte-mediated cytolysis.
METHODS
Preparation and assay of medullasin. Medullasin was purified and further crystallized from bone marrow cells obtained from resected human ribs according to the method described (1) . After removal of polyethylene glycol by CMcellulose column chromatography the protease was dissolved in 0.05 M acetate buffer (pH 5.0) and stored at 4°C. Since medullasin inactivates specifically the apo-form of certain pyridoxal enzymes, medullasin activity in mature granulocytes was measured by the use of apo-ornithine transaminase as substrate (1, 2) . Mature granulocytes (5 X 106-1 X 107) suspended in 3 ml of phosphate-buffered saline (pH 7.5) were sonicated at 50 W for 15 s in a 50-ml centrifuge tube (model W 185, Branson Sonic Power Co., Danbury, CT). From the precipitate obtained by centrifuging the sonicated solution at 20,000 g for 15 min the protease was extracted with 1 ml of 0.5 M potassium phosphate buffer (pH 7.0) at 370C for 30 min. One unit was defined as the amount of protease inactivating 50% of apo-ornithine transaminase under the conditions described (1). Tubes containing < 6 U of medullasin activity were used for the determination of activity, and the reaction was stopped at 10 min to determine the remaining ornithine transaminase activity.
Preparation of lymphocytes and mature granulocytes. Heparinized peripheral blood (30- phate-buffered saline by centrifugation, 1 ml of the IgG fraction was added and incubated for 30 min at 370C. After incubation the erythrocytes were washed twice in phosphatebuffered saline by centrifugation and suspended in RPMI 1640 (2 X 109/ml). To 1 ml of the lymphocyte suspension in RPMI 1640 (4-5 X 107/ml) 1 ml of antibody coated ox erythrocytes was added, and incubated at 37°C for 40 min after centrifugation at 140 g for 5 min. Tubes containing ox erythrocytes without antibody instead of those coated with antibody served as control. After incubation the cell suspensions were layered on top of an equal volume of Lymphoprep, and centrifuged at 400 g for 30 min. The cell layer formed between the sample and Lymphoprep was collected and washed two times in phosphate-buffered saline by centrifugation to obtain lymphocytes without Fc receptors (>95% of lymphocytes beared no Fc receptors). 2 ml of water was added to the pellet obtained by the Lymphoprep centrifugation followed immediately by the addition of 2 ml of two times concentrated RPMI 1640 medium. It was washed two times in phosphate-buffered saline by centrifugation to obtain the fraction enriched in lymphocytes bearing Fc receptors (50-60% of lymphocytes beared Fc receptors).
Determination of natural killer cell activity of lymphocytes cultured with mature granulocytes. Tubes containing both lymphocytes (1.5 X 106/ml) and mature granulocytes (1.3 X 106/ml) in 2 ml of RPMI 1640 supplemented with 20% autologous serum and antibiotics were incubated at 37°C for 24 h in a humidified 5% CO2 atmosphere. Tubes without mature granulocytes served as control. After incubation the cell suspensions (10 ml) were applied on Sephadex G-10 column (2.5 X 9 cm) equilibrated with RPMI 1640 containing 10% autologous serum. The eluate from the column contained negligible amount of granulocytes (<2%). Lymphocytes obtained from the eluate of the column were washed two times in RPMI 1640, suspended in RPMI 1640 (2 X 106/ml) supplemented with 10% fetal calf serum and antibiotics, and further incubated at 370C for 24 h in a humidified 5% CO2 atmosphere to be assayed for natural killer cell activity.
Measurement of the release of medullasin from granulocytes. Zymosan particles (Sigma Chemical Co.) preopsonized by incubating with fresh serum at 370C for 30 min were washed twice in Hanks' solution. Mature granulocytes (3 X 107) obtained from normal donors were incubated at 370C for 30 min in the presence or absence of zymosan (2 mg/ml) in 1 ml of RPMI 1640 (pH 7.5). After centrifugation medullasin activity was measured in the supernatant.
Interferon. Human interferon-,B produced in human diploid foreskin fibroblasts was supplied from Toray Ind. Inc., Tokyo. Human interferon-a prepared by Dr. K. Cantell (Helsinki) was kindly supplied by Dr. S. Kobayashi (Toray Basic Research Laboratories, Kamakura, Japan). Interferon titers in the supernatant of lymphocyte cultures were kindly measured by Dr. T. Nagashima (Toray Basic Research Laboratories, Kamakura, Japan) by inhibition of the cytopathic effect of sindbis virus on a FL cell monolayer according to the method of Havell and Vilcek (29) . Antiviral units were expressed as the reciprocal of the titer inhibiting 50% of the cytopathic effect using National Institutes of Health standard of human interferon-a.
Cytotoxicity assay. K-562 cells (myeloid leukemia) and Molt-4 cells (T-cell leukemia) were used as the target cells for 51Cr-release assay. Target cells (1-5 X 106) suspended in 0.2 ml of RPMI 1640 containing both 10% fetal calf serum and antibiotics were incubated with 75 MCi 51Cr (Na251CrO4, Japan Atomic Energy Research Institute, Ibaragi, Japan) at 370C for 2 h. The labeled target cells were then washed three times in phosphate-buffered saline (pH 7.5) and resuspended in RPMI 1640 medium containing both 10% fetal calf serum and antibiotics at 2.5 X 105 cells/ml. Various number of effector cells (0.16 ml) and 1 X 104 target cells were added to 13 X 100-mm tubes in triplicate in a final volume of 0.2 ml, and were incubated at 370C for 5 h in a humidified 5% CO2
atmosphere. Maximum 51Cr release was determined by the addition of 0.16 ml of 10% Triton X-100, and spontaneous 51Cr release by the addition of 0.16 ml of medium alone to the tube in triplicate instead of the lymphocyte suspensions. The values of cytotoxicity were calculated from the following formula:
Of _experimental release -spontaneous release maximum release -spontaneous release Spontaneous release ranged between 10 and 20% of the maximum. The cytotoxic activity of lymphocytes was also expressed as lytic units per 106 lymphocytes. One lytic unit is the number of cells required to cause 30% specific 51Cr release.
RESULTS
Enhancement of natural killer cell activity by the treatment with medullasin. Natural killer cell activity of lymphocytes obtained from normal donors was markedly enhanced by the treatment with medullasin when the cytotoxicity was measured 24 h after the treatment. A typical result is shown in Fig. 1 . The stimulatory effect of medullasin was equally observed whether K-562 cells or Molt-4 cells were used as target cells.
Dependence of the stimulatory effect of medullasin on the incubation period after the treatment. Fig. 2 shows that the enhancement of natural cytotoxicity by mnedullasin depends upon incubation periods after the treatment. Stimulatory effect of medullasin on the natural cytotoxicity was not significant when examined immediately after the treatment with medullasin. Enhancement of the natural killer cell activity by medullasin became evident when lymphocytes treated with medullasin were incubated at 370C for 6 h in a humidified 5% CO2 atmosphere. The effect of medullasin treatment was maximum at 24-h incubation, thereafter the stimulatory effect gradually decreased. When the mononuclear cell fraction (84-92% lymphocytes and 8-16% of monocytes) obtained by centrifuging the peripheral blood on Lymphoprep was used for the treatment with medullasin, rather inhibitory effect was observed when the cytotoxicity was measured immediately after the treatment. However, the stimulatory effect of medullasin was almost the same as that obtained by using pure lymphocytes when the natural killer cell activity was measured 24 h after the treatment.
Dose dependence. The relationship between the amounts of medullasin used and enhancement of natural killer cell activity was examined (Fig. 3) . Maximum stimulation was observed when lymphocytes were treated with 20 yg/ml of medullasin for 1 h.
Dependence on incubation time. Natural killer cell activity of lymphocytes treated with 20 ug/ml of medullasin for various hours is shown in Fig. 4 FIGURE 4 Stimulation of the natural killer cell activity as a function of incubation time. Lymphocytes (2 X 106/ml) suspended in RPMI 1640 were incubated at 370C for various hours in a humidified 5% CO2 atmosphere in the presence of medullasin (20 ,ug/ml). The reaction was terminated and assayed for the natural killer cell activity as described in Fig. 3 . Stimulation index shows the same as that in Fig. 2 . Bars, standard deviation of triplicate determinations. activity depends on its protease activity. Whereas an incubation of lymphocytes with phenylmethylsulfonyl fluoride (0.1 mM) at 37°C for 1 h did not affect the natural killer cell activity, treatment of lymphocytes with medullasin (10 ,g/ml) for 1 h at 37°C in the presence of phenylmethylsulfonyl fluoride (0.1 mM) remarkably inhibited the enhancement of natural cytotoxicity (Fig. 5) . (Medullasin activity was inhibited by 85% in the presence of 0.1 mM phenylmethylsulfonyl fluoride.) Furthermore, although an incubation of lymphocytes with elastatinal (20 ,g/ml) at 37°C for 60 min had no effect on the natural killer cell activity, treatment of lymphocytes with medullasin in the presence of elastatinal (20 ,ug/ml), the inhibitor of this protease, markedly diminished the stimulatory effect of medullasin (medullasin activity was decreased by 75% in the presence of 20 Medullasin activity in lymphocytes. Medullasin activity in lymphocytes was measured using lymphocytes eluted from Sephadex G-10 column as the enzyme source. No medullasin activity was detected. Also the protease activity was not detected even when the mononuclear cell fraction containing 8-16% of monocytes besides lymphocytes was used for the enzyme source. Furthermore, the mononuclear cell fraction (2 X 106/ml) obtained from Lymphoprep centrifugation was incubated in RPMI 1640 medium containing 10% autologous serum at 37°C for 48-72 h in a humidified 5% CO2 atmosphere in the presence of concanavalin A (Sigma Chemical Co., 10 ,g/ml) or phytohemagglutinin (Gibco Laboratories, 15 ,ug/ml). No medullasin activity was detected in these cultured lymphocytes. Also no medullasin activity was detected in the culture medium when the mononuclear cell fraction was incubated in RPMI 1640 medium without serum in the presence of concanavalin A or phytohemagglutinin at 370C for 48-72 h in a humidified 5% CO2 atmosphere.
Release of medullasin into culture medium from mature granulocytes. The release of medullasin from granulocytes was examined by incubating mature granulocytes in RPMI 1640 medium in the presence or absence of zymozan (2 mg/ml). As shown in Fig. 6 , medullasin release from mature granulocytes was prominent (25% of total) when incubated at 37°C for 30 min in the presence of zymosan. Considerable amounts of medullasin (3.5%) were also released even when mature granulocytes were incubated in the absence of zymosan.
Natural killer cell activity of lymphocytes cultured with granulocytes. As shown in Fig. 7 Effect of medullasin on the natural killer cell activity of the lymphocytes stimulated with interferon. Various amounts of interferon-aY were added to the lymphocyte suspensions treated with medullasin (20 ,ug/ml) for 60 min at 37°C, followed by an incubation for 24 h at 37°C in a humidified 5% C02 atmosphere to be assayed for natural killer cell activity. The same amounts of interferon-a were also added to the lymphocyte suspensions not treated with medullasin. Results are shown in Fig. 8 (25, 30) . Also both antibody-dependent cell-mediated cytotoxicity and natural killer cell activity were inhibited by serine protease inhibitors and substrates (26) (27) (28) FIGURE 8 Effect of medullasin on the natural killer cell activity of lymphocytes stimulated with interferon. Tubes containing lymphocytes (2 X 106/ml) in RPMI 1640 were treated with 20 Asg/ml medullasin at 370C for 60 min, followed by the addition of 10% fetal calf serum, antibiotics, and various amounts of interferon-a. Control tubes were those treated in the absence of medullasin. Tubes were then incubated at 370C for 24 h in a humidified 5% CO2 atmosphere to be assayed for the natural cytotoxicity. Each tube contained the following lymphocytes: 0, lymphocytes stimulated with interferon; and 0, lymphocytes treated with medullasin and further stimulated with interferon. Stimulation index shows the same as that in Fig. 2 . Bars, standard deviation of triplicate determinations. mal donors is 5-10 gg/ml. A large amount of medullasin was released from mature granulocytes into culture medium when incubated in the presence of zymosan. Considerable amount of the protease was released also into culture medium even when granulocytes were incubated at 370C for 30 min in the absence of zymosan. Although medullasin activity is inhibited completely in plasma owing to the presence of plasma protease inhibitors (1), it is quite possible that medullasin in mature granulocytes acts directly on the surface of lymphocytes because of the close relationship between granulocytes and lymphocytes in hemopoietic organs, peripheral blood, and various other tissues. In fact, lymphocytes cultured with granulocytes in the presence of serum showed an elevated natural killer cell activity when measured after 24 h incubation at 37°C. It is considered from these results that the natural killer cell activity is regulated in vivo by the medullasin of granulocytes. Medullasin activity in mature granulocytes is the highest in man as compared with that in other animals (1). Therefore, it seems probable that the natural killer cell activity in man is more intimately regulated by the medullasin than that in other animals.
The natural killer cell activity was reported to be modified by a variety of agents as described in the Introduction. Effects of proteases on the natural killer cell activity were also reported. Although natural cytotoxicity of lymphocytes obtained from lymph nodes was resistant to trypsin treatment (32) , that of lymphocytes obtained from peripheral blood decreased by the treatment with trypsin, pronase, and papain (8, 33) . Incubation of lymphocytes treated with trypsin at 370C for 3 h in autologous serum restored the natural killer cell activity to original levels, but did not increase it above control levels (33) . Therefore, the effect of medullasin on the natural killer cell activity is considered to be quite different from that of these proteases described above. An enhanced cytotoxicity brought about by medullasin treatment is not attributable to a direct effect on target cells, because medullasin activity was completely inhibited by the addition of fetal calf serum before the contact with target cells, and also because an increment of the cytotoxicity was not brought about immediately after the treatment with the protease. It also seems improbable that medullasin stimulated directly natural killer cells in releasing their lysosomal enzymes to lyse target cells, since the protease did not enhance the natural cytotoxicity immediately after the treatment. Since interferon enhanced natural killer cell activity immediately after the treatment (13) , stimulatory effect of medullasin on natural killer cells seems different from that of interferon. In fact, negligible activity of interferon was demonstrated in the supernatant of lymphocyte cultures that were stimulated by medullasin treatment. Furthermore, as shown in Results, medullasin further enhanced the natural killer cell activity of lymphocytes stimulated with interferon. These results indicate that the enhancement of natural killer cell activity by medullasin treatment is not mediated through interferon production. Since granulocytes obtained from rats injected with BCG as well as those from rats during carcinogenesis showed elevated medullasin activity (manuscript in preparation), it is also possible that several natural killer cellactivating agents which have been attributed to an enhanced production of interferon may act through activation of this protease of granulocytes. Medullasin also activated RNA and DNA synthesis of human lymphocytes (will be published elsewhere) and therefore, this protease may stimulate natural killer cell activity directly or through enhanced production of lymphokines (22 
